Shenzhen YHLO Biotech Co., Ltd. (688575.SS) SHH

Currency In CNY

AD

Valuation

Market Cap8.53B
Enterprise Value8.99B
P/E Ratio80.02
PEG Ratio-1.49
Price/Sales Ratio3.19
Price/Book Ratio2.19
Enterprise/Revenue3.35
Enterprise/EBITDA17.04

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue1.81B
Revenue/Share3.31
Gross Profit1.81B
EBITDA481.96M
Net Income23.34M
Diluted EPS0.04

Balance Sheet

Total Cash705.67M
Total Cash/Share1.24
Total Debt1.01B
Total Debt/Equity0.37
Current Ratio2.14
Book Value Per Share4.8

Price History

52-Week Change-27.63
52-Week High17
52-Week Low8.34
Moving Average 50 Days9.7
Moving Average 200 Days12.13

Statistics

Average Volume10.96M
Shares Outstanding571.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.02
Trailing Annual Dividend Yield0.2
Payout Ratio0.45
Last Split Factor7:5
Last Split DateJune 02, 2022
AD